1. Introduction {#sec1}
===============

T lymphocyte cells are defined by the expression of CD3^+^ molecules. The most important cell-surface molecules for identifying T lymphocyte subpopulations have been CD4^+^, CD8^+^, and T-cell receptor complex molecules (CD3^+^, the T-cell receptor *α* and *β* chains \[[@B1]\].

Those cells which express CD4^+^ and CXCR4 cell-surface molecules serve as a receptor and coreceptor for human immunodeficiency virus (HIV), respectively. HIV infects CD4^+^ T lymphocytes mainly, replicates within them, and lyses the cells as the replicated virions are released extracellularly to infect yet other CD4^+^ cells \[[@B2]\].

In advanced disease, most of the observed immune defects can ultimately be explained by the quantitative depletion of CD4^+^ T lymphocytes and the severity is reflected by measures of the absolute CD4^+^ T lymphocyte numbers per blood volume, the percentages of CD4^+^ lymphocyte (CD4^+^%) among lymphocytes, and also the CD4^+^/CD8^+^ ratio \[[@B3]\].

CD4^+^ T lymphocyte cells coordinate the immune system\'s response to the pathogens \[[@B4]\], and hence, normal reference interval values are critically important for the correct interpretation of diagnostic tests \[[@B5]\]. The influence of geographical location, racial and ethnic background, age, sex, and conditions of living on the distribution of human peripheral blood T lymphocyte subpopulations has already been documented in various studies of a given population in different parts of the world \[[@B6]--[@B8]\].

Few studies conducted in Africa show significant reference range variations of CD4^+^ T-cell and CD8^+^ T-cells within African populations because of environmental, sociodemographic differences and because of biological influences such as age, altitude, and ethnic origin \[[@B9]--[@B12]\].

Ethiopia has great geographical diversity \[[@B13]\], but in the national context, reference values for Ethiopians have never been established, despite a very few attempts in few localities which showed variation from other countries \[[@B14]\].

For appropriate diagnosis, treatment, and follow-up of patients, correct interpretation of the laboratory results is mandatory since it helps clinicians. This is attained by the knowledge of normal reference intervals that have been established at local setting than using references from western countries which have different climate, socioeconomic status, living style and genetic makeup, and so forth \[[@B15]\]. This study is, therefore, planned to provide normal reference intervals of T lymphocytes subsets and CD4^+^ to CD8^+^ cells ratio for the population of Gondar, North West Ethiopia.

2. Materials and Methods {#sec2}
========================

2.1. Study Design and Study Subjects {#sec2.1}
------------------------------------

Cross-sectional study was conducted from April to May, 2013, at the voluntary counseling and HIV testing clinic of University of Gondar Hospital and all laboratory investigations were done in the antiretroviral therapy laboratory of the hospital, Gondar town, North West Ethiopia. This laboratory, according to Ethiopian National Accreditation Office (ENAO), which established the Stepwise Laboratory (Quality) Improvement Process towards Accreditation (SLIPTA), has got 3 stars (75--84%) ranked from 5 stars (≥95%). ENAO gives recognition based on progress towards meeting requirements set by international standards and on laboratory performance during the 12 months preceding the SLIPTA audit, relying on complete and accurate data, to improve quality of public health laboratories in developing countries to achieve ISO 15189 standards.

All study participants who were free from clinical disease conditions, looking apparently healthy, whose age groups 18 to 64 years old, who lived in the area at least in the past for six months, being negative for HIV-1/2 antibodies, and having body mass index between 16.5 Kg/M^2^ and 22 Kg/M^2^ were included. The participants giving history of the recent enteric, respiratory infections and malaria and chronic noninfectious illnesses like diabetes mellitus, chronic renal disease, allergies, recent past immunization in the last 6 months, steroid therapy in the past three months, antibiotic usage four weeks prior to enrollment, and blood or blood product transfusion in the past 6 months were excluded. Female participants who were pregnant after being confirmed by human chorionic gonadotropin (hcG) tests were also excluded from the study.

A total of 320 individuals were included based on the recommended guideline of Clinical and Laboratory Standards Institute (CLSI) \[[@B16]\]. Accordingly this CLSI, a priori sampling method was conducted that requires well-defined exclusion and partitioning criteria before the selection of the reference individuals.

2.2. Data Collection and Processing {#sec2.2}
-----------------------------------

Prior to actual data collection, the clarity of the tool was assessed using 5% of the total sample size on other study areas. In addition, training about data collection was given for data collectors, two HIV counselor nurses and three laboratory technologists. All specimens from study subjects were handled following the standard operating procedures. Possible diurnal variations for T lymphocyte counts were controlled by collecting blood only at the specified hours in the morning (between 8:30 and 10:30 a.m.). The proper functioning of instruments, laboratory reagents, and technical performance were checked daily using quality control samples before running participant samples and along with participant samples.

Using the semistructured and pretested questionnaire sociodemographic characteristics and relevant clinical data were collected by face-to-face interview from the study participants. Five (5) mL of whole blood for all HIV1/2 antibodies screening CD3^+^, CD4^+^, CD8^+^,  and CD4^+^ to CD8^+^ ratio T lymphocytes counts was collected in tripotassium ethylenediaminetetraacetic acid (K~3~EDTA) vacutainer tubes.

Participant\'s specimen screened for the presence of  HIV antibodies using HIV-1/2 rapid test assay (using KHB, STAT Pack, and UNIGOLD) following the manufacturer\'s instruction and the national test algorism. This HIV serology was carried out anonymously with all sociodemographic characteristics. Those confirmed negative for HIV1/2 antibodies women were requested to check their pregnancy by One Step Strip Style hCG Pregnancy Test. Finally, all HIV negative individuals and nonpregnant women samples were assayed for CD3^+^,  CD4^+^,  CD8^+^, and CD4 to CD8 ratio T lymphocytes count.

All samples for T lymphocytes count processed and counted within 8 hrs of collection at the ART Laboratory, according to the instructions of the manufacturer. The blood collected with BD vacutainer tubes was well mixed and 50 *μ*L of the whole blood was transferred into monoclonal antibodies reagent tubes for FACSCount analysis to enumerate the T lymphocytes.

In brief, 50 *μ*L of whole blood was mixed with monoclonal antibodies (MAbs) (5 *μ*L of each T lymphocytes reagent tubes) and incubated at room temperature for 15 min in separate tubes and was placed in the dark place. By adding of fluorescence-activated cell sorter lysing solution (50% diethylene glycol and 15% formaldehyde) (Becton Dickinson) erythrocytes were lysed. After vortexing the tubes, it was incubated in the dark at room temperature for 15 minutes. Cells were injected into a "flow cell" which is located in the optical path of a light source, analyzed, and counted using a fluorescence-activated cell sorting count machine (*Becton Dickinson* FACSCount flow cytometer); here, the cells come in contact with the laser light, which causes the fluorochrome-labeled cells to fluoresce. This fluorescent light provides the necessary information for the instrument to count the cells.

2.3. Data Analysis {#sec2.3}
------------------

Data were entered and cleaned first using Epi-Info version 3.5.1 and then exported to SPSS version 20 for analysis. The mean, median, and standard deviation of normal reference interval values was calculated. Reference interval was determined as 95th percentile of the ordering data. *P* values less than 0.05 were considered statistically significant.

2.4. Ethical Clearance and Consent {#sec2.4}
----------------------------------

Ethical clearance was secured from the ethical review committee of the School of Biomedical and laboratory Science, University of Gondar. Official letter from University of Gondar Teaching Hospital Director office was obtained and submitted to both VCT center and antiretroviral therapy laboratory coordinator. Written informed consent was taken from each study participant. Those participants, who had HIV infection, were referred to the HIV care and treatment clinic for further management after counseling. Female participants who were reactive for hcG test were referred to antenatal clinic for better care.

3. Results {#sec3}
==========

A total of 320 study participants were included in the study with mean age of 25.3 ± 7.7 years old. Out of the total 320 study participants, 161 (50.3%) were men and 159 (49.7%) were women. Men were older than women, with mean ages of 27 ± 8 years and 23.5 ± 6 years, respectively. The majority of the study participants were 224 (70%) single in marital status and were 95 (29.7%) students in their occupational status; concerning educational status most of participants 116 (36.3%) were 9th--12th grades and 292 (91.3%) Amhara ethnic ([Table 1](#tab1){ref-type="table"}). The overall mean, median, and the 95% normal reference interval values for absolute CD3^+^, CD4^+^, and CD8^+^ T lymphocyte count and also for absolute CD4^+^ to CD8^+^ ratio were established for the participants ([Table 2](#tab2){ref-type="table"}).

T lymphocyte subset values in HIV-1/2 seronegative individuals are reported to be affected by different factors like gender, age, and geographical location worldwide. In this study also as overall the age increases, there was decline in the value of CD8^+^ T lymphocytes ([Table 3](#tab3){ref-type="table"}).

The absolute mean of CD3^+^ (1567 ± 562 cells/*μ*L) and CD4^+^ (759 ± 252 cells/*μ*L) T lymphocytes for men is statistically lower than women (1706 ± 547 cells/*μ*L) (*P* = 0.01) and (822 ± 275 cells/*μ*L) (*P* = 0.00), respectively, but there was no statistically significant difference in the mean absolute count for CD8^+^ T lymphocytes (*P* = 0.18) and CD4^+^ to CD8^+^ ratio of lymphocytes between male and female (*P* = 0.26).

4. Discussion {#sec4}
=============

The mean and the upper limit reference interval results CD3^+^ T lymphocyte counts were higher than the user\'s guideline mean: 1206 and (reference interval: 688--1955) cells/*μ*L. The mean of CD3^+^ T lymphocyte count for women participants was significantly higher than from those men participants (*P* = 0.01).

The median (reference interval) of these lymphocytes in women seems slightly greater than the study conducted in other parts of Ethiopian median (reference interval). In addition, median and the upper limit of men CD3^+^ T lymphocyte of the current study show a higher result than men participants median and reference interval of their study, as studied by Kassu et al. \[[@B17]\], and lower from the study done in South West Ethiopia median (reference range) 1,643 (760--3,465) by Haileamlak et al. \[[@B18]\]; this could result from the difference of study subject since we used apparently healthy individuals whereas their study groups were clinically assessed specially in the Kassu et al. study. CD3^+^ T lymphocytes mean, median, and 95% reference interval of the current study are comparable with the study done in Kenya, median and reference interval \[[@B19]\].

The 95% reference interval for the absolute CD4^+^ T lymphocyte count for the participants was lower and a slight wider than the current national guideline for ART users and FACSCount user guideline (reference interval: 470--1298 cells/*μ*L) may be because of racial difference among the study subjects. Results of mean and median values for CD4^+^ T lymphocytes were greater than from the result of study done in Akaki factory worker by Tsegaye et al., Addis Ababa, Ethiopia (775 ± 225, 761 cells/*μ*L) and for the present study 95% normal reference interval (321--1389 cells/*μ*L) lower limit nearly lower than there (366--1235 cells/*μ*L) \[[@B14]\] could be due to geographical difference. CD4^+^ T lymphocytes count was consistent with the study done in Tanzania \[[@B10]\] and Botswana blood donors \[[@B20]\].

However, the values of CD4^+^ T lymphocytes mean, median, and 95% normal reference interval were lower than from the study done in Kenya \[[@B19]\], Uganda (mean: 938, reference interval: 418--2105 cells/*μ*L) \[[@B8]\], Central Africa Republic study done by Menard et al. (mean: 940, median: 912, reference interval: 386--1454 cells/*μ*L) \[[@B21]\], healthy Nigerian adults done (mean: 847, reference interval: 365--1571 cells/*μ*L) \[[@B11]\]; this was again maybe by different geographical location.

The absolute median count of CD4^+^ T lymphocytes for men (737 cells/*μ*L) and women (858 cells/*μ*L) was statistically different in the present study and lower than the study done by Torres et al. in the two regions of Brazil blood donors, that is, the study in Bahia/Pará men absolute count (897/768 cells/*μ*L) and for women (1032/802 cells/*μ*L) \[[@B7]\] maybe because of the use of apparently healthy study subjects in the current study.

The overall mean and median CD8^+^ T lymphocyte counts show similarity from the study done by Tsegaye et al. so far other parts of Ethiopia. CD8^+^ T lymphocyte counts show great difference from the FACSCount user guideline (mean: 346, reference interval: 208--796); it might be because of the large sample size used in the present study and/or racial diversity. Women mean and median of CD8^+^ T lymphocytes counts were higher than men but it is not statistically significant (*P* = 0.18).

Similarities had also observed between men and women of the current results (women\'s median value: 667, 95% normal reference interval: 241--1667) (men\'s median value: 623, 95% normal reference interval: 206--1733 cells/*μ*L) from the previous study done by Kassu et al. in Ethiopia (women median value: 617, range 258--1301 cells/*μ*L) (men\'s median value 619, reference range: 249--1,933 cells/*μ*L) from Akaki, but the upper limit of 95% normal reference interval for men (206--1733 cells/*μ*L) was completely higher than the values of men those found in Wonji (range: 180--1253 cells/*μ*L) \[[@B17]\]; probably it could be environmental factors ([Table 4](#tab4){ref-type="table"}).

The absolute CD8^+^ T lymphocytes mean, median, and the 95% normal reference interval value for the current study were also greater than the studies conducted from Switzerland by Bisset et al. (median: 347, range: 137--823 cells/*μ*L) \[[@B22]\], Shanghai, China (mean: 539, median: 503, range: 336--780 cells/*μ*L) \[[@B23]\], Asian population (mean: 642, median: 616, reference range: 243--1206 cells/*μ*L) \[[@B24]\]; the difference could be on our apparently healthy study population whereas they used only blood donors especially in Asian population and Switzerland studies, we used more numbers of study subjects in the current study but the study done in Switzerland used 70 individual healthy blood donors, or it may be due to the high parasitic prevalence and high microbial infection in the local area which can contribute to the increased number of absolute CD8^+^ T lymphocyte counts, since once CD8^+^ T lymphocytes are activated, they will have long life span.

Absolute CD4^+^ to CD8^+^ ratio T lymphocytes mean, median, and 95% normal reference interval were lower than from women\'s, but the difference was not statistically significant (*P* = 0.26).

Furthermore the result of this gender specific ratio in the current study (males median: 1.23, normal reference interval: 0.4--2.8) (females median: 1.26, normal reference interval: 0.6--2.5) is in line with the study conducted Akaki (males median: 1.10, reference range: 0.41--2.57) (females median: 1.2, reference range: 0.52--2.60), and also Wonji (males median 1.4, range: 0.6--2.80), south east of Ethiopia \[[@B17]\].

The gender specific result CD4^+^ to CD8^+^ ratio (males mean: 1.3 ± 0.5, normal reference interval: 0.4--2.8) (females mean: 1.34 ± 0.5, normal reference interval: 0.6--2.5) of the current study was lower than from the study done in Uganda (males mean: 1.47, range: 0.54--3.94) (females mean: 1.46, range: 0.48--4.41) \[[@B8]\].

Overall the result of CD4 to CD8 T lymphocytes ratio in the current study was lower than the study from Kenya \[[@B19]\], Tanzania \[[@B10]\], Nigeria \[[@B11]\], and India \[[@B25]\]. As compared to the study done in Switzerland \[[@B22]\] and Asian population \[[@B24]\], the current results also show great variation ([Table 5](#tab5){ref-type="table"}), since our life style exposed to different infectious organism and the high prevalence of infection for the current study have been implicated as possible explanation to reduce CD4/CD8 T-cell ratios.

5. Conclusions {#sec5}
==============

The overall CD3^+^ T lymphocytes reference values were high and its interval was very wide.

The mean and 95% normal reference interval values for absolute CD4^+^ T lymphocyte strength the earlier reports done from Ethiopia and other African studies; it was low CD4^+^ T lymphocyte. In general, in this study, very high CD8^+^ T lymphocytes counts and very low CD4^+^ to CD8^+^ ratio were observed; so the current reference interval results should be applicable only for the study area. Since the reference value for CD4^+^ T lymphocyte is low in the current study from the national reference and user guidelines also, physician should use a higher CD4^+^ T lymphocytes cutoff values for initiation of ART drugs and highly recommended to establish local reference interval for each laboratory.
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###### 

Sociodemographic characteristics of HIV1/2 negative adults who visited VCT in University of Gondar Hospital, Ethiopia, 2013.

  Sociodemographic characteristic   Number of participants   Percent (%)
  --------------------------------- ------------------------ -------------
  Marital status                                              
   Single                           224                      70
   Married                          48                       15
   Divorced                         46                       15.4
   Widowed                          2                        0.6
  Occupational status                                         
   Student                          95                       29.7
   Farmer                           37                       11.6
   Daily labor                      36                       11.3
   Merchant                         31                       9.7
   Housewife                        24                       7.5
   Teacher                          7                        2.2
   Driver                           5                        1.6
   Others                           85                       26.6
  Educational status                                          
   Illiterates                      50                       15.6
   1--8th                           94                       29.4
   9--12th                          116                      36.3
   \>12th                           60                       18.8
  Ethnic groups                                               
   Amhara                           292                      91.3
   Kimant                           12                       3.8
   Oromo                            3                        0.9
   Tigray                           2                        0.6
   Others                           11                       3.4

###### 

Means, medians, and 95th percentile reference intervals of CD3^+^, CD4^+^, CD8^+^, and CD4 to CD8 ratio of HIV negative adults who visited VCT, University of Gondar Hospital, Ethiopia, 2013.

  Participants    Average CD3^+^/*µ*L   Absolute CD4^+^/*µ*L   Absolute CD8^+^/*µ*L   CD4 : CD8 ratio
  --------------- --------------------- ---------------------- ---------------------- -----------------
  Male = (161)                                                                         
   Mean ± SD^∗^   1567 ± 562            759 ± 252              705 ± 370              1.3 ± 0.5
   Median         1485                  737                    623                    1.23
   95% range      611--2974             265--1685              206--1733              0.4--2.8
  Female (159)                                                                         
   Mean ± SD      1706 ± 547            882 ± 275              739 ± 342              1.34 ± 0.5
   Median         1675                  858                    667                    1.26
   95% range      828--2824             387--1411              241--1667              0.6--2.5
  Total (320)                                                                          
   Mean ± SD      1636 ± 559            820 ± 270              722 ± 356              1.3 ± 0.5
   Median         1574                  774                    650                    1.2
   95% range      655--2823             321--1389              220--1664              0.5--2.52

^*∗*^SD = standard deviation.

###### 

The mean reference value of T lymphocytes subpopulation/*µ*L blood in HIV negative adults who visited VCT, University of Gondar Hospital, Ethiopia by age and sex, 2013.

  Age group (yrs.)   Gender                                                                                                         
  ------------------ --------- --------- --------- --------- --------- --------- --------- ---------- --------- --------- --------- ---------
  18--25             96        791       735       1.3       122       891       740       1.4        218       847       737       1.3
  26--35             46        705       662       1.3       25        884       764       1.3        71        768       698       1.3
  36--45             15        761       649       1.4       10        854       721       1.4        25        798       678       1.4
  46--60             2         565       876       0.6       2         485       472       1.2        4         525       674       0.9
  \>60               2         636       534       2         ---       ---       ---       ---        2         636       534       2.0
  Total              **161**   **759**   **705**   **1.3**   **159**   **882**   **739**   **1.34**   **320**   **820**   **722**   **1.3**

###### 

Gender based 95% reference interval of HIV negative adults visited VCT, University of Gondar Hospital, Ethiopia, 2013, as compared with other countries.

  ---------------------------------------------------------------------------------------------------------
  Parameter               Current study   Ethiopia     CAR          Nigeria      India        Switzerland
  ----------------------- --------------- ------------ ------------ ------------ ------------ -------------
  Males                                                                                       

  CD3^+^/*µ*L             611--2974       759--2742    NA           NA           NA           521--1772

  CD4^+^/*µ*L             265--1685  \    391--1145    380--1617    351--1455    383--1347    336--1126
                          355--1213^∗^                                                        

  CD8^+^/*µ*L             206--1733       249--1933    267--1545    155--863     NA           125--780

  CD4 : CD8 ratio/*µ*L    0.4--2.8        0.41--2.57   0.34--1.88   0.7--5.1     NA           0.9--6.0

                                                                                              

  Females                                                                                     

  CD3^+^/*µ*L             828--2824       741--2329    NA           NA           NA           595--1861

  CD4^+^/*µ*L             387--1411  \    386--1355    386--1454    383--1654    448--1593    314--1270
                          470--1298^∗^                                                        

  CD8^+^/*µ*L             241--1667       258--1301    226--1225    133--919     NA           147--836

  CD4 : CD8 ratio/*µ*L    0.6--2.50       0.52--2.60   0.6--2.27    0.8--5.8     NA           1.0--4.9

  References in numbers                   \[[@B17]\]   \[[@B21]\]   \[[@B11]\]   \[[@B25]\]   \[[@B22]\]
  ---------------------------------------------------------------------------------------------------------

^*∗*^User\'s guideline values, NA = not available.

###### 

The overall 95% normal reference interval for Tlymphocytes in HIV negative adults in the current study as compared to other African countries.

  Parameter               User\'s guideline   Current study   Previous study in Ethiopia   Kenya        Tanzania     Uganda      Nigeria
  ----------------------- ------------------- --------------- ---------------------------- ------------ ------------ ----------- ------------
  CD3^+^/*µ*L             688--1955           655--2823       NA                           744--2634    NA           NA          NA
  CD4^+^/*µ*L             500--1300           321--1389       366--1235                    421--1550    312--1367    418--2105   365--1571
  CD8^+^/*µ*L             208--796            220--1664       311--1618                    210--1081    168--996     256--1619   145--884
  CD4 : CD8 ratio/*µ*L    0.83--6.10          0.5--2.5        0.4--2.4                     0.9--3.3     1.1--2.5     0.52--4.1   0.5--5.3
  References in numbers                                       \[[@B14]\]                   \[[@B19]\]   \[[@B10]\]   \[[@B8]\]   \[[@B11]\]

NA = not available.
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